Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2022-08-12 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2022 年半年度报告摘要' which translates to '2022 Semi-Annual Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, cash flow, earnings per share, and shareholder information. The document is a summary of the half-year report, which is a comprehensive financial report for a period shorter than a full fiscal year. The length is 2646 characters, which is typical for a summary but still contains substantive financial data and analysis. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-12 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the supervisory board of Chengdu Berry Genomics Co., Ltd. regarding the approval of the company's 2022 semi-annual report (half-year report). It states that the supervisory board has reviewed and approved the full text and summary of the 2022 half-year report, confirming compliance with laws and regulations and the accuracy of the report. The document is short (684 characters) and primarily serves as a meeting resolution announcement rather than containing the actual financial data or detailed report itself. Therefore, it is not the interim/quarterly report (IR) itself but an announcement related to the approval of such a report. However, since it is a formal resolution announcement by the supervisory board about the report, it fits best under Regulatory Filings (RNS), which covers compliance documents and announcements that do not contain the full report data.
2022-08-12 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from the company Chengdu Berry Genomics Co., Ltd. It reports the approval of the 2022 semi-annual report (half-year report) by the board of directors. The document includes details about the meeting, attendance, and voting results. It states that the full semi-annual report will be published on the same day on a public information website and in newspapers, indicating this document itself is not the full report but an announcement of the board's approval of the interim report. The document length is short (658 characters), and it does not contain actual financial statements or substantive financial data, only the resolution and voting results. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official announcement related to the interim report but not the report itself.
2022-08-12 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding the company's controlling shareholders and related parties occupying company funds and external guarantees. It references legal and regulatory frameworks and provides specific details about guarantees and fund occupation during the reporting period. The content is a formal independent directors' report on specific governance and financial matters, not a full annual or interim report, audit report, or earnings release. It is a standalone report focusing on governance and financial guarantees, which fits best under Audit Report / Information (AR) as it involves verification and independent opinion on financial and related party matters. H1 2022
2022-08-12 Chinese
关于控股股东及其一致行动人进行股票质押式回购交易补充质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the supplementary pledge of shares by the controlling shareholder and its concerted parties. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company capital, and other related information. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging activities, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like share issue or director dealings. The document length is short and it is a formal disclosure of share pledge status, typical of regulatory filings in the Chinese market.
2022-08-08 Chinese
关于变更职工代表监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of a company's employee representative supervisor (监事) due to resignation and election of a new representative. It includes details about the resignation, election process, and qualifications of the new supervisor. There is no financial data, no mention of financial results, no regulatory filings about financial performance, no voting results, and no mention of any report publication. The content is about management/board changes specifically related to supervisory board members. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on personnel changes, not a report or announcement of a report.
2022-07-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.